Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection

Cureus. 2022 Apr 25;14(4):e24461. doi: 10.7759/cureus.24461. eCollection 2022 Apr.

Abstract

Hyaluronic acid dermal fillers are a very popular choice for patients wanting to undergo non-invasive facial rejuvenation. Its prevalence is predicted to continue to rise. We report a case of delayed angioedema and associated urticaria to hyaluronic acid dermal fillers post COVID-19 infection. To our knowledge, this is an unusual case of hypersensitivity reaction of eight-month latency. Although the aetiology warrants further research, the author suggests utilisation of a four-week time window between dermal filler injections and COVID-19 vaccination.

Keywords: aesthetic medicine; corona virus; covid 19; delayed hypersensitivity; dermal filler.

Publication types

  • Case Reports